Utilizing Active Fluidics at Reduced Intraocular Pressure Alleviates Intraoperative Discomfort During Phacoemulsification: A Propensity Score-Matched Analysis - Summary - MDSpire
Advertisement
Utilizing Active Fluidics at Reduced Intraocular Pressure Alleviates Intraoperative Discomfort During Phacoemulsification: A Propensity Score-Matched Analysis
To compare intraoperative discomfort and early postoperative outcomes between phacoemulsification using the Centurion Vision System (active fluidics at lower intraocular pressure) and the Stellaris Elite System (gravity-based fluidics at higher IOP).
Key Findings:
Active Fluidics Group had significantly fewer patients requiring supplemental anesthesia (3.1% vs. 13.8%; p = 0.028).
Median pain scores were lower in the Active Fluidics Group (1 vs. 3; p < 0.001).
Day-1 CCT increase was smaller with active fluidics (28.4 vs. 46.8 μm; p < 0.001).
No intraoperative complications occurred, and ECD loss and final visual acuity were comparable between groups.
Interpretation:
Phacoemulsification using active fluidics at lower IOP significantly reduces intraoperative discomfort and early postoperative corneal edema, while ensuring safety and maintaining visual outcomes.
Limitations:
Single-center study may limit generalizability; results may not apply to broader populations.
Short follow-up period of 1 month may not capture long-term outcomes, necessitating further research.
Conclusion:
Active fluidics technology improves patient comfort during phacoemulsification and reduces early postoperative corneal edema without compromising safety or visual outcomes.
